Transformative changes related to submission management has become a popular discussion in many global forums over the past few years, as drug submissions continue to shift towards standardized formats, increasing in volume and complexity.
But what does the next chapter in this journey look like? What are the most pressing challenges and what trends can already be identified? This is the question addressed by our colleagues Lorelle Leonienco and Charles Mathis, defining the next chapter in submission management modernization as “Dynamic Submission Management (DSM)”. This evolution of change will offer many opportunities to both industry, health organizations, and technology vendors.